| Cash Flow | 2025-07-31 | 2025-04-30 | 2024-10-31 | 2024-07-31 |
|---|---|---|---|---|
| Net loss (including amounts attributable to redeemable non-controlling interests) | -63,404 | -35,641 | -86,983 | -58,856 |
| Stock-based compensation | 68,198 | 30,643 | 87,184 | 58,756 |
| Amortization of deferred contract costs | 19,451 | 9,421 | 26,004 | 16,979 |
| Depreciation and amortization | 7,372 | 2,606 | 7,368 | 4,732 |
| Provision for credit losses | 600 | 232 | 2,157 | 369 |
| Value of common stock donated to charity | 1,860 | 1,109 | 2,764 | 1,347 |
| (accretion) amortization of (discount) premium on marketable securities | -654 | -399 | -1,605 | -1,043 |
| Non-cash foreign exchange (gain) loss | -209 | -227 | 802 | 485 |
| Fair value adjustments to contingent consideration | 0 | 0 | -223 | -137 |
| Fixed asset write offs | - | - | 436 | - |
| Other | -28 | 9 | -1 | -287 |
| Accounts receivable | -11,549 | -9,108 | 227 | -20,689 |
| Prepaid expenses and other current assets | -5,036 | -3,147 | 1,365 | 2,004 |
| Deferred contract costs | 24,814 | 11,870 | 34,764 | 22,009 |
| Rou assets and liabilities | 314 | 410 | -2,123 | -2,307 |
| Other assets | 8,451 | 403 | 506 | -670 |
| Accounts payable | -1,159 | -978 | -3,326 | -1,644 |
| Accrued expenses and other current liabilities | 1,218 | -7,203 | 2,105 | 3,352 |
| Deferred revenue | 14,493 | 24,547 | 19,517 | 7,828 |
| Other long-term liabilities | -122 | -1 | -261 | -131 |
| Net cash provided by operating activities | 31,096 | 24,144 | 19,597 | 31,007 |
| Cash paid for acquisition, net of cash acquired | 181,200 | - | 0 | 0 |
| Purchases of property and equipment | 2,826 | 217 | 12,147 | 10,224 |
| Capitalized internal-use software costs | 1,865 | 1,055 | 3,023 | 2,108 |
| Purchases of marketable securities | 75,115 | 52,364 | 179,545 | 142,099 |
| Maturities of marketable securities | 102,540 | 63,215 | 159,086 | 127,000 |
| Return of principal on marketable securities | 120,753 | 113,258 | - | - |
| Cash flows from financing activities | -37,713 | 122,837 | -35,629 | -27,431 |
| Proceeds from exercise of common stock options | 3,201 | 605 | 3,682 | 2,205 |
| Proceeds from stock associated with employee stock purchase plan | 4,882 | - | 4,752 | 4,752 |
| Payments of deferred purchase consideration | 0 | 0 | 2,916 | 2,916 |
| Net cash provided by financing activities | 8,083 | 605 | 5,518 | 4,041 |
| Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash | 642 | 851 | 225 | -99 |
| Net change in cash, cash equivalents, and restricted cash | 2,108 | 148,437 | -10,289 | 7,518 |
Braze, Inc. (BRZE)
Braze, Inc. (BRZE)